Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Palantir

Bearish Analyst Expects Palantir Technologies Stock to Sink 26%

Palantir stock has more than doubled over the past year, but the latest analyst note from Deutsche Bank calls for the stock to enter its own personal bear market over the next year. Here's a closer look at Wall Street's latest pessimistic take on PLTR.

Barchart

Palantir Stock Pops, Briefly Reclaims 50-Day Moving Average

Shares in Palantir popped Monday, reclaiming the 50-day moving average for PLTR stock.

Investors Business Daily

Palantir Is Down, But Its FCF Could Make It Worth 21% More at $20 Per Share

Palantir Technologies stock is off its peak of $21.26 per share. But its powerful free cash flow could push PLTR stock up over 21% to that peak. One way investors can play this is to short OTM puts.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Down 21%, Is Palantir Stock a Buy Right Now?

Palantir stock has pulled back sharply from its post-earnings peak - but the shares still trade at a premium, and Wall Street analysts think there may be more downside in store for this AI stock over the short term.

Barchart

PLTR vs. META: Which AI Growth Stock is Wall Street's Favorite for 2024?

While both Palantir and Meta Platforms are positioned for a stronger AI-fueled future in 2024, Wall Street is bullish on one stock's long-term prospects - and cautiously optimistic on the other.

Barchart

Palantir (PLTR) and UiPath (PATH) - Buy, Hold, or Sell in 2024?

The software industry has been put under strain as a result of macroeconomic concerns. However, the future of the industry looks optimistic. Therefore, let us analyze whether software stocks Palantir Technologies (PLTR) and UiPath (PATH) are Buy, Hold, or Sell now.

StockNews.com

Dow Jones Fades Off Highs After Jobs Report; Bitcoin Miner Marathon Digital Plunges 10%

The Dow Jones turned lower in afternoon trading Friday, while several top-rated growth stocks rebounded after recent weakness.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Palantir Downgraded By Jefferies, Called 'Overhyped On AI'

Calling Palantir Technologies "overhyped on AI," Jefferies analyst Brent Thill on Friday downgraded PLTR stock to underperform.

Investors Business Daily

Dow Jones Rallies 150 Points On Strong Jobs Report; AI Leader Palantir Slides On Downgrade

The Dow Jones Industrial Average rallied 150 points Friday on a strong December jobs report. AI leader Palantir dived on an analyst downgrade.

Investors Business Daily

My plan to topple the Tory dark lords in 2024

We need a fellowship of socially conscious heroes to fight the Conservatives and NHS data-grabbing firms and save our democracy

The Guardian - UK

Good Law Project: US tech giant is offering to pay influencers to 'attack' us

THE Good Law Project has claimed a US tech giant has hired a PR firm to pay influencers to attack it on social media amid its investigation into an…

The National (Scotland)

Health workers blockade office of tech giant with NHS contract over ties to Israel

Demonstrators blockaded the central London office of US tech giant Palantir after it was awarded a contract worth hundreds of millions of pounds for…

The National (Scotland)

Protesters blockade London office of tech giant with NHS contract over ties to Israel

Dozens of pro-Palestine demonstrators blocked the entrance to Palantir in central London

Evening Standard

Google Leads 4 AI Stocks Battling Back Toward Buy Points. Why They Deserve A Close Look.

Google leads this week's list of AI stocks that are rebounding back near buy points after recent sell-offs.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Palantir Receives $115 Million Army Contract Extension; PLTR Stock Pushes Higher Before Closing Flat

PLTR stock briefly traded higher early Friday on a one-year extension of Palantir's contract with the U.S. Army.

Investors Business Daily

Palantir Stock Briefly Reclaims 50-Day Average Before Giving Up Gains

Palantir stock, which sank more than 12% last week, advance early Monday before giving up those gains to trade flat.

Barchart

Is Palantir Stock Really Headed to Just $5 Per Share?

Palantir stock has more than doubled in 2023, but lost 9% to start the week after a bearish analyst note. Are concerns about the AI software company's contract pipeline overdone, or is major downside ahead for the stock in 2024?

Investors Business Daily

Palantir Falls As Analyst Raises Questions Over Army Contract Renewal

Palantir stock's strong run in 2023 is running into more headwinds with a bearish analyst on PLTR stock raising questions over an Army contract renewal.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Palantir Still Has Room to Rise, and Could Be Worth Up to 20% More

Palantir stock is still undervalued given its powerful free cash flow. With a 27% FCF margin and an FCF yield of 1.5% PLTR stock is worth 20% more. Shorting OTM puts is a good income play.

The Guardian - UK

You may balk at giving your health data to Palantir but it could save your life

The NHS’s deal with the US tech company raises privacy concerns but a unified database could be a medical gamechanger

Investors Business Daily

Dow Jones Futures Fall; ARM, Palantir Lead 7 Stocks In Buy Areas

Futures signaled a lower open Monday. Arm Holdings and D.R. Horton flashed buy signals Friday.

The Conversation

Palantir: privacy fears over handing NHS data to US defence provider show how lack of trust is holding back much-needed reform

Controversial US tech company Palantir has been awarded a £330 million contract to create a new system for sharing data – including patients’ medical details – within the NHS in England.

The National (Scotland)

SNP MP grills Rishi Sunak over US tech firm's NHS contract

SNP MP Deidre Brock grilled Rishi Sunak at PMQs on Wednesday over NHS England’s awarding of an IT contract to US tech firm Palantir.

Investors Business Daily

Dow Jones Futures Rise: Market Holds Strong, Tesla, Palantir Rally; Two Big Earnings Winners

The major indexes held near 2023 highs Tuesday. Tesla cleared a key level heading into the Cybertruck delivery event.

The Guardian - UK

The Guardian view on the NHS and Palantir: the case for this data deal looks weak

Editorial: Hiring a controversial US technology company to build an NHS data platform risks undermining public trust

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations